Literature DB >> 31238561

Psychotropic Drugs for the Management of Chronic Pain and Itch.

Daria A Belinskaia1, Mariia A Belinskaia2, Oleg I Barygin3, Nina P Vanchakova4, Natalia N Shestakova5.   

Abstract

Clinical observations have shown that patients with chronic neuropathic pain or itch exhibit symptoms of increased anxiety, depression and cognitive impairment. Such patients need corrective therapy with antidepressants, antipsychotics or anticonvulsants. It is known that some psychotropic drugs are also effective for the treatment of neuropathic pain and pruritus syndromes due to interaction with the secondary molecular targets. Our own clinical studies have identified antipruritic and/or analgesic efficacy of the following compounds: tianeptine (atypical tricyclic antidepressant), citalopram (selective serotonin reuptake inhibitor), mianserin (tetracyclic antidepressant), carbamazepine (anticonvulsant), trazodone (serotonin antagonist and reuptake inhibitor), and chlorprothixene (antipsychotic). Venlafaxine (serotonin-norepinephrine reuptake inhibitor) is known to have an analgesic effect too. The mechanism of such effect of these drugs is not fully understood. Herein we review and correlate the literature data on analgesic/antipruritic activity with pharmacological profile of these compounds.

Entities:  

Keywords:  animal model; chronic pain; clinical trial; pharmacological profile; psychotropic drugs

Year:  2019        PMID: 31238561      PMCID: PMC6631469          DOI: 10.3390/ph12020099

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  7 in total

1.  Nutritional and Metabolic Factors, Ethanol and Cholesterol, Interact With Calcium-Dependent N-Methyl-D-Aspartate Receptor Inhibition by Tricyclic Antidepressants.

Authors:  Sergei I Boikov; Dmitry A Sibarov; Sergei M Antonov
Journal:  Front Cell Neurosci       Date:  2022-07-04       Impact factor: 6.147

2.  Attenuation of the Diffuse Noxious Inhibitory Controls in Chronic Joint Inflammatory Pain Is Accompanied by Anxiodepressive-Like Behaviors and Impairment of the Descending Noradrenergic Modulation.

Authors:  Raquel Pereira-Silva; José Tiago Costa-Pereira; Raquel Alonso; Paula Serrão; Isabel Martins; Fani L Neto
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

Review 3.  Neuropharmacological Effects of Mesaconitine: Evidence from Molecular and Cellular Basis of Neural Circuit.

Authors:  Zhihui Sun; Limin Yang; Lihong Zhao; Ranji Cui; Wei Yang
Journal:  Neural Plast       Date:  2020-08-21       Impact factor: 3.599

4.  Trazodone effects on developing brain.

Authors:  Zeljka Korade; Luke B Allen; Allison Anderson; Keri A Tallman; Thiago C Genaro-Mattos; Ned A Porter; Karoly Mirnics
Journal:  Transl Psychiatry       Date:  2021-02-01       Impact factor: 6.222

5.  Doxepin prevents the Expression and Development of Paclitaxel-Induced Neuropathic Pain.

Authors:  Hajar Naji Esfahani; Golnaz Vaseghi; Shaghayegh Haghjooy Javanmard; Aliasghar Pilehvarian
Journal:  Adv Biomed Res       Date:  2021-11-26

6.  Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors.

Authors:  Yulia D Stepanenko; Dmitry A Sibarov; Natalia N Shestakova; Sergei M Antonov
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

Review 7.  Characteristics, mechanism, and management of pain in atopic dermatitis: A literature review.

Authors:  Jia-Xin Li; Rui-Jia Dong; Yue-Ping Zeng
Journal:  Clin Transl Allergy       Date:  2021-12       Impact factor: 5.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.